Osteosarcoma in Korean children and adolescents

Osteosarcoma is the most frequent primary bone tumor. Advances in combination chemotherapy and surgical technique have greatly improved the survival of patients with osteosarcoma. In Korea, improvements in osteosarcoma treatment have been made over the past two decades. The 5-year event-free surviva...

Full description

Bibliographic Details
Main Author: Jun Ah Lee
Format: Article
Language:English
Published: Korean Pediatric Society 2015-04-01
Series:Korean Journal of Pediatrics
Subjects:
Online Access:http://kjp.or.kr/upload/pdf/kjped-58-123.pdf
_version_ 1818988542091591680
author Jun Ah Lee
author_facet Jun Ah Lee
author_sort Jun Ah Lee
collection DOAJ
description Osteosarcoma is the most frequent primary bone tumor. Advances in combination chemotherapy and surgical technique have greatly improved the survival of patients with osteosarcoma. In Korea, improvements in osteosarcoma treatment have been made over the past two decades. The 5-year event-free survival rate of Korean children and adolescents with localized disease is 64.6%, comparable to that of American or European patients. This article provides an overview of current therapies for osteosarcoma in Korea.
first_indexed 2024-12-20T19:24:14Z
format Article
id doaj.art-ac3176ed131e420e9982bdc4b17539ff
institution Directory Open Access Journal
issn 1738-1061
2092-7258
language English
last_indexed 2024-12-20T19:24:14Z
publishDate 2015-04-01
publisher Korean Pediatric Society
record_format Article
series Korean Journal of Pediatrics
spelling doaj.art-ac3176ed131e420e9982bdc4b17539ff2022-12-21T19:28:55ZengKorean Pediatric SocietyKorean Journal of Pediatrics1738-10612092-72582015-04-0158412312810.3345/kjp.2015.58.4.12320125550469Osteosarcoma in Korean children and adolescentsJun Ah Lee0Department of Pediatrics, Korea Cancer Center Hospital, Seoul, Korea.Osteosarcoma is the most frequent primary bone tumor. Advances in combination chemotherapy and surgical technique have greatly improved the survival of patients with osteosarcoma. In Korea, improvements in osteosarcoma treatment have been made over the past two decades. The 5-year event-free survival rate of Korean children and adolescents with localized disease is 64.6%, comparable to that of American or European patients. This article provides an overview of current therapies for osteosarcoma in Korea.http://kjp.or.kr/upload/pdf/kjped-58-123.pdfOsteosarcomaKoreaChildAdolescents
spellingShingle Jun Ah Lee
Osteosarcoma in Korean children and adolescents
Korean Journal of Pediatrics
Osteosarcoma
Korea
Child
Adolescents
title Osteosarcoma in Korean children and adolescents
title_full Osteosarcoma in Korean children and adolescents
title_fullStr Osteosarcoma in Korean children and adolescents
title_full_unstemmed Osteosarcoma in Korean children and adolescents
title_short Osteosarcoma in Korean children and adolescents
title_sort osteosarcoma in korean children and adolescents
topic Osteosarcoma
Korea
Child
Adolescents
url http://kjp.or.kr/upload/pdf/kjped-58-123.pdf
work_keys_str_mv AT junahlee osteosarcomainkoreanchildrenandadolescents